Conditions: Type 2 Diabetes Mellitus (T2DM)
Keywords: T2DM obesity safety multiple dose intravenous
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 4
Healthy volunteers: no

Brief summary:
This is a trial in obese subjects to study the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of PF-05231023.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Placebo intervention 2: 100 mg PF-05231023
Intervention descriptions: intervention 1: 0.9% w/v sodium chloride injection, United States Pharmacopeia (USP), twice a week for 4 weeks. intervention 2: 100 mg IV infusion twice a week for 4 weeks

Protocol document: